Saturday, March 29, 2014 8:07:44 PM
.125 range or higher?
It would still be only 50% of Napadano's price target of .24.
Let's see what surprises Gerald has for the shorts on Monday.
Word is getting out about LymPro.
Must read if you haven't read them yet:
The Life Sciences Report – “From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing”
http://www.thelifesciencesreport.com/pub/na/from-lab-bench-to-bedside-david-lowe-brings-common-sense-to-neuroscience-investing
How Alzheimer’s Blood Test Could Paradoxically Change the Long-Term Care Market
http://seekingalpha.com/article/2114603-how-alzheimers-blood-tests-could-paradoxically-free-the-long-term-care-market
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM